Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study-Reference-Cited by-同舟云学术

Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study

Published:2016-07-08 Issue:2 Volume:56 Page:165-177
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Lévi Francis,Karaboué Abdoulaye,Etienne-Grimaldi Marie-Christine,Paintaud Gilles,Focan Christian,Innominato Pasquale,Bouchahda Mohamed,Milano Gérard,Chatelut Etienne

Funder

ARTBC INTERNATIONAL

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-016-0431-2.pdf

Reference44 articles.

1. Kemeny NE, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27(21):3465–71.

2. Bouchahda M, et al. Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer. Eur J Cancer. 2011;47(18):2681–90.

3. Kemeny NE, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24(9):1395–403.

4. Mocellin S, et al. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol. 2007;25(35):5649–54.

5. Arai Y, et al. Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI. J Vasc Interv Radiol. 2012;23(10):1261–7.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer;Clinical and Translational Science;2024-05

2. Dosing‐time, feeding, and sex‐dependent variations of everolimus pharmacokinetics in mice;Fundamental & Clinical Pharmacology;2024-03-18

3. Shaping the future of precision oncology: Integrating circadian medicine and mathematical models for personalized cancer treatment;Current Opinion in Systems Biology;2024-03

4. Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy;Clinical Pharmacology & Therapeutics;2024-01-24

5. Crosstalk between Circadian Rhythm Dysregulation and Tumorigenesis, Tumor Metabolism and Tumor Immune Response;aging and disease;2024